• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素受体通过 circRNA7/miRNA7-5p/VE-cadherin/Notch4 信号通路抑制肝癌中的血管生成拟态。

Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling.

机构信息

School of Life Sciences, Anhui Medical University, Hefei, China.

Departments of General Surgery, the First Affiliated Hospital of Anhui Medical University, Hefei, China.

出版信息

J Cell Mol Med. 2020 Dec;24(23):14110-14120. doi: 10.1111/jcmm.16022. Epub 2020 Oct 28.

DOI:10.1111/jcmm.16022
PMID:33118329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7754040/
Abstract

Androgen receptor (AR) can suppress hepatocellular carcinoma (HCC) invasion and metastasis at an advanced stage. Vasculogenic mimicry (VM), a new vascularization pattern by which tumour tissues nourish themselves, is correlated with tumour progression and metastasis. Here, we investigated the effect of AR on the formation of VM and its mechanism in HCC. The results suggested that AR could down-regulate circular RNA (circRNA) 7, up-regulate micro RNA (miRNA) 7-5p, and suppress the formation of VM in HCC Small hairpin circR7 (ShcircR7) could reverse the impact on VM and expression of VE-cadherin and Notch4 increased by small interfering AR (shAR) in HCC, while inhibition of miR-7-5p blocked the formation of VM and expression of VE-cadherin and Notch4 decreased by AR overexpression (oeAR) in HCC. Mechanism dissection demonstrated that AR could directly target the circR7 host gene promoter to suppress circR7, and miR-7-5p might directly target the VE-cadherin and Notch4 3'UTR to suppress their expression in HCC. In addition, knockdown of Notch4 and/or VE-cadherin revealed that shVE-cadherin or shNotch4 alone could partially reverse the formation of HCC VM, while shVE-cadherin and shNotch4 together could completely suppress the formation of HCC VM. Those results indicate that AR could suppress the formation of HCC VM by down-regulating circRNA7/miRNA7-5p/VE-Cadherin/Notch4 signals in HCC, which will help in the design of novel therapies against HCC.

摘要

雄激素受体(AR)可在晚期抑制肝细胞癌(HCC)的侵袭和转移。血管生成拟态(VM)是一种新的血管生成模式,肿瘤组织通过该模式为自身提供营养,与肿瘤的进展和转移相关。在此,我们研究了 AR 对 HCC 中 VM 形成的影响及其机制。结果表明,AR 可以下调环状 RNA(circRNA)7,上调 microRNA(miRNA)7-5p,抑制 HCC 中 VM 的形成。小发夹 circR7(ShcircR7)可以逆转 AR 沉默(shAR)对 HCC 中 VM 形成和 VE-钙粘蛋白和 Notch4 表达的影响,而 miR-7-5p 的抑制则阻断了由 AR 过表达(oeAR)在 HCC 中降低的 VM 形成和 VE-钙粘蛋白和 Notch4 的表达。机制分析表明,AR 可以直接靶向 circR7 宿主基因启动子抑制 circR7,而 miR-7-5p 可能直接靶向 VE-钙粘蛋白和 Notch4 的 3'UTR 抑制它们在 HCC 中的表达。此外,敲低 Notch4 和/或 VE-钙粘蛋白表明,单独敲低 shVE-cadherin 或 shNotch4 可以部分逆转 HCC VM 的形成,而同时敲低 shVE-cadherin 和 shNotch4 则可以完全抑制 HCC VM 的形成。这些结果表明,AR 可以通过下调 HCC 中的 circRNA7/miRNA7-5p/VE-Cadherin/Notch4 信号来抑制 HCC 的形成,这有助于设计针对 HCC 的新治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/7754040/6723fb61737a/JCMM-24-14110-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/7754040/33d242b73b63/JCMM-24-14110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/7754040/b49444623421/JCMM-24-14110-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/7754040/aec5c18d8a34/JCMM-24-14110-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/7754040/93651b551a75/JCMM-24-14110-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/7754040/07b9e2132e50/JCMM-24-14110-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/7754040/1a36dd023aaa/JCMM-24-14110-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/7754040/6723fb61737a/JCMM-24-14110-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/7754040/33d242b73b63/JCMM-24-14110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/7754040/b49444623421/JCMM-24-14110-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/7754040/aec5c18d8a34/JCMM-24-14110-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/7754040/93651b551a75/JCMM-24-14110-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/7754040/07b9e2132e50/JCMM-24-14110-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/7754040/1a36dd023aaa/JCMM-24-14110-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f859/7754040/6723fb61737a/JCMM-24-14110-g007.jpg

相似文献

1
Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling.雄激素受体通过 circRNA7/miRNA7-5p/VE-cadherin/Notch4 信号通路抑制肝癌中的血管生成拟态。
J Cell Mol Med. 2020 Dec;24(23):14110-14120. doi: 10.1111/jcmm.16022. Epub 2020 Oct 28.
2
miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.微小RNA-27a-3p通过下调血管内皮钙黏蛋白表达和抑制上皮-间质转化来抑制肿瘤转移和血管生成拟态:Twist-1在肝癌中的重要作用
Sci Rep. 2016 Mar 16;6:23091. doi: 10.1038/srep23091.
3
Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells.Notch4抑制可抑制肝癌细胞的侵袭和血管生成拟态形成。
J Huazhong Univ Sci Technolog Med Sci. 2017 Oct;37(5):719-725. doi: 10.1007/s11596-017-1794-9. Epub 2017 Oct 20.
4
Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway.重楼皂苷 I 通过 Twist1/VE-cadherin 通路抑制血管生成拟态的形成。
Cell Death Dis. 2018 Sep 5;9(9):906. doi: 10.1038/s41419-018-0902-5.
5
ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.ZEB2通过TGF-β1诱导的上皮-间质转化促进肝细胞癌的血管生成拟态。
Exp Mol Pathol. 2015 Jun;98(3):352-9. doi: 10.1016/j.yexmp.2015.03.030. Epub 2015 Mar 26.
6
HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.低氧诱导因子-1α(HIF-1α)诱导食管癌细胞中血管内皮钙黏蛋白(VE-cadherin)的表达并调节血管生成拟态。
World J Gastroenterol. 2014 Dec 21;20(47):17894-904. doi: 10.3748/wjg.v20.i47.17894.
7
Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation.雄激素受体通过差异改变 miRNA525-5p/SLPI 介导的血管生成拟态形成来抑制前列腺癌转移但促进膀胱癌转移。
Cancer Lett. 2020 Mar 31;473:118-129. doi: 10.1016/j.canlet.2019.12.018. Epub 2019 Dec 13.
8
Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma.在肝细胞癌中,癌相关成纤维细胞的旁分泌转化生长因子-β(TGF-β)和基质细胞衍生因子1(SDF1)可促进血管拟态形成,而miR-101则对其有抑制作用。
Cancer Lett. 2016 Dec 1;383(1):18-27. doi: 10.1016/j.canlet.2016.09.012. Epub 2016 Sep 28.
9
Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1-mediated EMT.regorafenib 通过靶向 ID1 介导的 EMT 抑制肝癌的迁移、侵袭和血管生成拟态。
Mol Carcinog. 2021 Feb;60(2):151-163. doi: 10.1002/mc.23279. Epub 2021 Jan 11.
10
LncRNA n339260 functions in hepatocellular carcinoma progression via regulation of miRNA30e-5p/TP53INP1 expression.长链非编码 RNA n339260 通过调控 miRNA30e-5p/TP53INP1 的表达在肝癌进展中发挥作用。
J Gastroenterol. 2022 Oct;57(10):784-797. doi: 10.1007/s00535-022-01901-8. Epub 2022 Jul 8.

引用本文的文献

1
Biological roles and molecular mechanism of circular RNAs in epithelial-mesenchymal transition of gastrointestinal malignancies.环状RNA在胃肠道恶性肿瘤上皮-间质转化中的生物学作用及分子机制
Oncol Res. 2025 Feb 28;33(3):549-566. doi: 10.32604/or.2024.051589. eCollection 2025.
2
CircCCNB1 inhibits vasculogenic mimicry by sequestering NF90 to promote miR-15b-5p and miR-7-1-3p processing in nasopharyngeal carcinoma.环状CCNB1通过隔离NF90促进鼻咽癌中miR-15b-5p和miR-7-1-3p的加工,从而抑制血管生成拟态。
Mol Oncol. 2025 Jun;19(6):1876-1893. doi: 10.1002/1878-0261.13821. Epub 2025 Feb 18.
3
Testosterone Exacerbates the Formation of Liver Cancer Induced by Environmental N-Nitrosamines Exposure: Potential Mechanisms and Implications for Human Health.

本文引用的文献

1
JQ1 effectively inhibits vasculogenic mimicry of pancreatic ductal adenocarcinoma cells via the ERK1/2-MMP-2/9 signaling pathway both in vitro and in vivo.JQ1通过ERK1/2-MMP-2/9信号通路在体外和体内有效抑制胰腺导管腺癌细胞的血管生成拟态。
Am J Transl Res. 2019 Feb 15;11(2):1030-1039. eCollection 2019.
2
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
3
Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.
睾酮加剧环境N-亚硝胺暴露诱导的肝癌形成:潜在机制及其对人类健康的影响
Onco Targets Ther. 2024 May 17;17:395-409. doi: 10.2147/OTT.S456746. eCollection 2024.
4
Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer.《怪奇物语》:雄激素受体在肿瘤学中除前列腺癌以外的新角色和新机遇
Endocrinology. 2023 Apr 17;164(6). doi: 10.1210/endocr/bqad071.
5
Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches.靶向非编码RNA以开发新型肝细胞癌治疗方法
Pharmaceutics. 2023 Apr 15;15(4):1249. doi: 10.3390/pharmaceutics15041249.
6
The Clinical Application of Immunohistochemical Expression of Notch4 Protein in Patients with Colon Adenocarcinoma. Notch4 蛋白免疫组织化学表达在结肠癌患者中的临床应用。
Int J Mol Sci. 2023 Apr 19;24(8):7502. doi: 10.3390/ijms24087502.
7
Review of novel functions and implications of circular RNAs in hepatocellular carcinoma.环状RNA在肝细胞癌中的新功能及意义综述。
Front Oncol. 2023 Feb 20;13:1093063. doi: 10.3389/fonc.2023.1093063. eCollection 2023.
8
Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment.通过靶向肿瘤微环境克服肝癌的治疗耐药性。
Front Oncol. 2022 Nov 15;12:988956. doi: 10.3389/fonc.2022.988956. eCollection 2022.
9
Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.微小 RNA 的参与及其在肝细胞癌中的潜在诊断、治疗和预后作用。
J Clin Lab Anal. 2022 Oct;36(10):e24673. doi: 10.1002/jcla.24673. Epub 2022 Aug 29.
10
The function and regulation network mechanism of circRNA in liver diseases.环状RNA在肝脏疾病中的功能及调控网络机制
Cancer Cell Int. 2022 Mar 31;22(1):141. doi: 10.1186/s12935-022-02559-1.
评估血管生成拟态、Notch4、DLL4和KAI1/CD82在预测非小细胞肺癌转移和预后中的相关性。
Medicine (Baltimore). 2018 Dec;97(52):e13817. doi: 10.1097/MD.0000000000013817.
4
LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma.LOXL2 促进肝癌中的血管生成拟态和肿瘤侵袭性。
J Cell Mol Med. 2019 Feb;23(2):1363-1374. doi: 10.1111/jcmm.14039. Epub 2018 Dec 1.
5
Vasculogenic mimicry formation in EBV-associated epithelial malignancies.EBV 相关上皮性恶性肿瘤中的血管生成拟态形成。
Nat Commun. 2018 Nov 27;9(1):5009. doi: 10.1038/s41467-018-07308-5.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway.重楼皂苷 I 通过 Twist1/VE-cadherin 通路抑制血管生成拟态的形成。
Cell Death Dis. 2018 Sep 5;9(9):906. doi: 10.1038/s41419-018-0902-5.
8
Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma.Hsp90β 通过上皮-间充质转化促进肝癌侵袭性血管生成拟态。
Oncogene. 2019 Jan;38(2):228-243. doi: 10.1038/s41388-018-0428-4. Epub 2018 Aug 7.
9
TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals.TR4 核受体通过改变 miR490-3p/波形蛋白信号促进肾透明细胞癌(ccRCC)血管生成拟态(VM)形成和转移。
Oncogene. 2018 Nov;37(44):5901-5912. doi: 10.1038/s41388-018-0269-1. Epub 2018 Jul 4.
10
MicroRNA.微小 RNA
J Allergy Clin Immunol. 2018 Apr;141(4):1202-1207. doi: 10.1016/j.jaci.2017.08.034. Epub 2017 Oct 23.